Literature DB >> 24958971

Bupivacaine liposomal versus bupivacaine: comparative review.

John Noviasky1, Deirdre P Pierce2, Karen Whalen3, Roy Guharoy4, Kenneth Hildreth5.   

Abstract

Bupivacaine liposomal injection was recently approved by the US Food and Drug Administration (FDA) as a local anesthetic for use in management of postsurgical pain in adults. When compared to placebo, bupivacaine liposomal decreases postoperative pain and opioid use. This review examines the efficacy of bupivacaine liposomal when compared to conventional bupivacaine ± epinephrine using published and unpublished data provided to the FDA by the manufacturer.

Entities:  

Keywords:  bupivacaine; bupivacaine liposomal; formulary; pharmacoeconomics

Year:  2014        PMID： 24958971      PMCID： PMC4062733          DOI： 10.1310/hpj4906-539

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


  10 in total

1.  Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Stephen R Gorfine; Erol Onel; Gary Patou; Zoran V Krivokapic
Journal:  Dis Colon Rectum       Date:  2011-12       Impact factor: 4.585

2.  Perirectal block for out-patient anorectal surgery: a new technique.

Authors:  Germán A Díaz-Palacios; Javier H Eslava-Schmalbach
Journal:  Biomedica       Date:  2011-06       Impact factor: 0.935

3.  A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy.

Authors:  Michael Golf; Stephen E Daniels; Erol Onel
Journal:  Adv Ther       Date:  2011-08-12       Impact factor: 3.845

Review 4.  Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective, controlled clinical studies.

Authors:  Richard Baxter; Kenneth Bramlett; Erol Onel; Stephen Daniels
Journal:  Clin Ther       Date:  2013-03-01       Impact factor: 3.393

5.  Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting.

Authors:  Joseph Dasta; Sonia Ramamoorthy; Gary Patou; Raymond Sinatra
Journal:  Curr Med Res Opin       Date:  2012-09-03       Impact factor: 2.580

Review 6.  Pain outcomes: a brief review of instruments and techniques.

Authors:  Jarred Younger; Rebecca McCue; Sean Mackey
Journal:  Curr Pain Headache Rep       Date:  2009-02

7.  Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain.

Authors:  Keith Candiotti
Journal:  Pharmacotherapy       Date:  2012-09       Impact factor: 4.705

8.  Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs.

Authors:  Brigitte M Richard; Douglas E Rickert; Dannette Doolittle; Amy Mize; Jason Liu; Charles F Lawson
Journal:  ISRN Pharm       Date:  2011-12-27

9.  Liposomal bupivacaine: a review of a new bupivacaine formulation.

Authors:  Praveen Chahar; Kenneth C Cummings
Journal:  J Pain Res       Date:  2012-08-14       Impact factor: 3.133

10.  Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia.

Authors:  Sergio D Bergese; Sonia Ramamoorthy; Gary Patou; Kenneth Bramlett; Stephen R Gorfine; Keith A Candiotti
Journal:  J Pain Res       Date:  2012-05-01       Impact factor: 3.133
  10 in total
  3 in total

1.  Feasibility and safety of same day subcutaneous defibrillator implantation and send home (DASH) strategy.

Authors:  Toshimasa Okabe; Adrianne Miller; Tanner Koppert; Rafael Cavalcanti; Diego Alcivar-Franco; Jemina Osei; Omar Kahaly; Muhammad R Afzal; Jaret Tyler; Steven J Kalbfleisch; Raul Weiss; Mahmoud Houmsse; Ralph S Augostini; Emile G Daoud; Michael J Andritsos; Sujatha Bhandary; Galina Dimitrova; Kasey Fiorini; Hamdy Elsayed-Awad; Antolin Flores; Leonid Gorelik; Manoj H Iyer; Samiya Saklayen; Erica Stein; Katja Turner; William Perez; John D Hummel; Michael K Essandoh
Journal:  J Interv Card Electrophysiol       Date:  2019-12-07       Impact factor: 1.900

Review 2.  [Liposomal bupivacaine-No breakthrough in postoperative pain management].

Authors:  Berit Otremba; Hanns-Christian Dinges; Ann-Kristin Schubert; Wolfgang Zink; Thorsten Steinfeldt; Hinnerk Wulf; Thomas Wiesmann
Journal:  Anaesthesiologie       Date:  2022-04-25

3.  Use of Liposomal Bupivacaine for Postoperative Analgesia in an Incisional Pain Model in Rats (Rattus norvegicus).

Authors:  Stacey C Kang; Katechan Jampachaisri; Travis L Seymour; Stephen A Felt; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-01-01       Impact factor: 1.232
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.